KALA BIO, INC. Amortization of Debt Issuance Costs and Discounts
KALA BIO, INC. (KALA) reported Amortization of Debt Issuance Costs and Discounts of -$667.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Cash Flow › Operating Activities
us-gaap:AmortizationOfFinancingCostsAndDiscounts · last filed 2026-08-19
- KALA BIO, INC. amortization of debt issuance costs and discounts for the quarter ending 2025-12-31 was -$1.14M, a 481.94% decline year-over-year.
- KALA BIO, INC. amortization of debt issuance costs and discounts for the quarter ending 2025-09-30 was $116.00K, a 63.98% decline year-over-year.
- KALA BIO, INC. amortization of debt issuance costs and discounts for the quarter ending 2025-06-30 was $173.00K, a 45.08% decline year-over-year.
- KALA BIO, INC. amortization of debt issuance costs and discounts for the quarter ending 2025-03-31 was $186.00K, a 40.38% decline year-over-year.
- KALA BIO, INC. amortization of debt issuance costs and discounts for fiscal 2025 was -$667.00K, a 153.45% decline from fiscal 2024.
- KALA BIO, INC. amortization of debt issuance costs and discounts for fiscal 2024 was $1.25M, a 0.40% decline from fiscal 2023.
- KALA BIO, INC. amortization of debt issuance costs and discounts for fiscal 2023 was $1.25M, a 12.07% decline from fiscal 2022.
- KALA BIO, INC. amortization of debt issuance costs and discounts for fiscal 2022 was $1.43M, a 6.19% decline from fiscal 2021.
| Period end | Amortization of Debt Issuance Costs and Discounts 3 month | Amortization of Debt Issuance Costs and Discounts 6 month | Amortization of Debt Issuance Costs and Discounts 9 month | Amortization of Debt Issuance Costs and Discounts 12 month |
|---|---|---|---|---|
| 2025-12-31 | -$1.14M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | -$1.03M derived: sum of 2 quarters · filed 2026-04-15 | -$853.00K derived: sum of 3 quarters · filed 2026-08-19 | -$667.00K 10-K · filed 2026-04-15 |
| 2025-09-30 | $116.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | $289.00K derived: sum of 2 quarters · filed 2026-08-19 | $475.00K 10-Q · filed 2025-11-19 | $774.00K derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-06-30 | $173.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-19 | $359.00K 10-Q · filed 2026-08-19 | $658.00K derived: sum of 3 quarters · filed 2026-08-19 | $980.00K derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-03-31 | $186.00K 10-Q · filed 2026-05-15 | $485.00K derived: sum of 2 quarters · filed 2026-05-15 | $807.00K derived: sum of 3 quarters · filed 2026-05-15 | $1.12M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $299.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $621.00K derived: sum of 2 quarters · filed 2026-04-15 | $936.00K derived: sum of 3 quarters · filed 2026-04-15 | $1.25M 10-K · filed 2026-04-15 |
| 2024-09-30 | $322.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | $637.00K derived: sum of 2 quarters · filed 2025-11-19 | $949.00K 10-Q · filed 2025-11-19 | $1.26M derived: sum of 4 quarters · filed 2025-11-19 |
| 2024-06-30 | $315.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $627.00K 10-Q · filed 2025-08-08 | $939.00K derived: sum of 3 quarters · filed 2025-08-08 | $1.25M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | $312.00K 10-Q · filed 2025-05-14 | $624.00K derived: sum of 2 quarters · filed 2025-05-14 | $933.00K derived: sum of 3 quarters · filed 2025-05-14 | $1.24M derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $312.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $621.00K derived: sum of 2 quarters · filed 2025-03-31 | $924.00K derived: sum of 3 quarters · filed 2025-03-31 | $1.25M 10-K · filed 2025-03-31 |
| 2023-09-30 | $309.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $612.00K derived: sum of 2 quarters · filed 2024-11-12 | $941.00K 10-Q · filed 2024-11-12 | $1.24M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $303.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $632.00K 10-Q · filed 2024-08-06 | $927.00K derived: sum of 3 quarters · filed 2024-08-06 | $1.19M derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | $329.00K 10-Q · filed 2024-05-14 | $624.00K derived: sum of 2 quarters · filed 2024-05-14 | $883.00K derived: sum of 3 quarters · filed 2024-05-14 | $1.32M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $295.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $554.00K derived: sum of 2 quarters · filed 2024-03-29 | $993.00K derived: sum of 3 quarters · filed 2024-03-29 | $1.43M 10-K · filed 2024-03-29 |
| 2022-09-30 | $259.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $698.00K derived: sum of 2 quarters · filed 2023-11-13 | $1.13M 10-Q · filed 2023-11-13 | $1.57M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $439.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $871.00K 10-Q · filed 2023-08-04 | $1.31M derived: sum of 3 quarters · filed 2023-08-04 | $1.75M derived: sum of 4 quarters · filed 2023-08-04 |
| 2022-03-31 | $432.00K 10-Q · filed 2023-05-09 | $871.00K derived: sum of 2 quarters · filed 2023-05-09 | $1.31M derived: sum of 3 quarters · filed 2023-05-09 | $1.67M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $439.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-03 | $874.00K derived: sum of 2 quarters · filed 2023-03-03 | $1.24M derived: sum of 3 quarters · filed 2023-03-03 | $1.52M 10-K · filed 2023-03-03 |
| 2021-09-30 | $435.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $802.00K derived: sum of 2 quarters · filed 2022-11-08 | $1.08M 10-Q · filed 2022-11-08 | $1.36M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $367.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $645.00K 10-Q · filed 2022-08-11 | $922.00K derived: sum of 3 quarters · filed 2022-08-11 | $1.19M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $278.00K 10-Q · filed 2022-05-16 | $555.00K derived: sum of 2 quarters · filed 2022-05-16 | $824.00K derived: sum of 3 quarters · filed 2022-05-16 | $1.08M derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $277.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $546.00K derived: sum of 2 quarters · filed 2022-03-29 | $806.00K derived: sum of 3 quarters · filed 2022-03-29 | $1.06M 10-K · filed 2022-03-29 |
| 2020-09-30 | $269.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $529.00K derived: sum of 2 quarters · filed 2021-11-15 | $782.00K 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $260.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $513.00K 10-Q · filed 2021-08-05 | ||
| 2020-03-31 | $253.00K 10-Q · filed 2021-05-05 | |||
| 2019-12-31 | $958.00K 10-K · filed 2021-02-25 | |||
| 2019-03-31 | $231.00K 10-Q · filed 2019-05-09 | |||
| 2018-09-30 | $24.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $44.00K derived: sum of 2 quarters · filed 2018-11-08 | $75.00K 10-Q · filed 2018-11-08 | $100.00K derived: sum of 4 quarters · filed 2019-05-09 |
| 2018-06-30 | $20.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $51.00K 10-Q · filed 2018-08-09 | $76.00K derived: sum of 3 quarters · filed 2019-05-09 | $106.00K derived: sum of 4 quarters · filed 2019-05-09 |
| 2018-03-31 | $31.00K 10-Q · filed 2019-05-09 | $56.00K derived: sum of 2 quarters · filed 2019-05-09 | $86.00K derived: sum of 3 quarters · filed 2019-05-09 | $114.00K derived: sum of 4 quarters · filed 2019-05-09 |
| 2017-12-31 | $25.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $55.00K derived: sum of 2 quarters · filed 2018-11-08 | $83.00K derived: sum of 3 quarters · filed 2018-11-08 | $111.00K 10-K · filed 2018-04-02 |
| 2017-09-30 | $30.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $58.00K derived: sum of 2 quarters · filed 2018-11-08 | $86.00K 10-Q · filed 2018-11-08 | $109.00K derived: sum of 4 quarters · filed 2018-11-08 |
| 2017-06-30 | $28.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $56.00K 10-Q · filed 2018-08-09 | $79.00K derived: sum of 3 quarters · filed 2018-08-09 | $110.00K derived: sum of 4 quarters · filed 2018-08-09 |
| 2017-03-31 | $28.00K 10-Q · filed 2018-05-10 | $51.00K derived: sum of 2 quarters · filed 2018-05-10 | $82.00K derived: sum of 3 quarters · filed 2018-05-10 | |
| 2016-12-31 | $23.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $54.00K derived: sum of 2 quarters · filed 2018-04-02 | $106.00K 10-K · filed 2018-04-02 | |
| 2016-09-30 | $31.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $83.00K 10-Q · filed 2017-11-07 | ||
| 2016-06-30 | $52.00K 10-Q · filed 2017-08-31 | |||
| 2015-12-31 | $134.00K 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |